Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $148.4300 (-4.53%) ($147.1100 - $158.0800) on Tue. Nov. 13, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.92% (three month average) | RSI | 39 | Latest Price | $148.4300(-4.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.4% a day on average for past five trading days. | Weekly Trend | LGND declines -2.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.46% in a week (0% probabilities). TLT(-16%) VXX(-15%) VIXM(-12%) UUP(-9%) GDXJ(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.46% (StdDev 2.92%) | Hourly BBV | 0 () | Intraday Trend | -4.6% | | | |
|
Resistance Level | $170.04 | 5 Day Moving Average | $159.33(-6.84%) | 10 Day Moving Average | $161.5(-8.09%) | 20 Day Moving Average | $170.04(-12.71%) | To recent high | -45.9% | To recent low | 0% | Market Cap | $2.385b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |